SubHero Banner
Text

2nd Quarter 2024

Key topics in this quarter’s edition include:

  • Dupixent (dupilumab) for treatment of chronic obstructive pulmonary disease
  • Xanomeline/trospium for treatment of schizophrenia
  • Insulin icodec for treatment of diabetes mellitus 

Download PDF

Text